Back to All Collaborations

GSK-Barclays: Live Well

Active Since: 2013

Contributing to SDGs…

Unblocking financial barriers and enhancing government efforts to help increase access to affordable healthcare.

PARTNER ORGANISATIONS

  • Government

    Zambian Ministry of Health

  • Financial institutions

    Barclays

Objectives

  • Availability - develop a private sector supply chain to help reduce stock shortages and deliver essential medicines to rural areas.
  • Access - establish small enterprise health outlets to deliver affordable healthcare in areas where people may otherwise have to travel significant distances to access basic healthcare.
  • Affordability - test a micro health insurance product to help low-income people more easily afford medicines and healthcare services.
  • Awareness - strengthen health education to help reduce sickness and mitigate its economic impact on poorer communities.

Despite substantial economic growth in Africa over the last few decades, access to affordable healthcare remains one of the greatest challenges to sustained economic development. Sub-Saharan Africa accounts for 11% of the world’s population, yet bears 24% of the global disease burden and commands less than 1% of global health expenditure. It also faces a severe shortage of trained medical personnel, with just 3% of the world’s health workers deployed in Sub-Saharan Africa.

The partnership shared vision is that in the future, economically sustainable and resilient health systems will be able to deliver affordable and accessible quality healthcare across Africa, while increasing access to financial products, supporting small business development and creating jobs.

To help achieve this, the partnership implemented a pilot in Zambia to explore and address the economic and financial barriers that currently exist in health systems across Africa. The partnership was designed to align with the Zambian government’s National Health plans. Hon Joseph Kasonde, Minister of Health, Zambia has said: “We are very pleased to support the Barclays GSK Program which aligns well with priorities in the Zambian National Health Strategic Plan.”

By the end of 2018 Barclays and GSK had together invested approximately £7m in financial support and on-the-ground resource over a 5 year period, with the ambitious goal of reaching 1 million out of the total population of 14 million people living in Zambia.

In Zambia, the partnership has set up the social enterprise, Live Well, in collaboration with CARE which tests a new route to market for GSK. Live Well recruits, trains and supports a network of Community Health Entrepreneurs (CHEs) in peri-urban and rural areas to promote healthcare and sell health impact products into underserved communities.

The partnership works closely with other organisations such as government, NGOs and civil society as they develop thinking and plans. GSK hopes that ultimately, by working together, such partnership can help unblock financial barriers and enhance government efforts to help increase access to affordable healthcare, ensuring the project is locally owned and self-sustaining.

Quote
"This innovative partnership has potential to develop sustainable private sector solutions that complement government efforts to improve essential medical supplies and healthcare for under-served communities in Zambia."
Hon. Joseph Kasonde,
Minister of Health, Zambia

SDGs THE PARTNERSHIP CONTRIBUTES TO

SDG 3: Good Health and Wellbeing

  1. 3.1: Reduce Maternal Mortality
  2. 3.2: Reduce Under-5 Mortality 
  3. 3.3: Communicable Diseases & NTDs
  4. 3.4: NCDs (including mental health)
  5. 3.7: Access to sexual and reproductive health-care services 

SDG 5: Gender Equality

SDG 10: Reduced Inequalities

SDG 17: Partnerships for the Goals 

RESULTS & MILESTONES

The partnership was recognised by the Clinton Global Initiatives as a 2013 Commitment to Action.

In Zambia, the partnership has set up the social enterprise, Live Well, in collaboration with CARE. Since the beginning of this project, over 300 Community Health Entrepreneurs have been recruited and 15,000 GSK products sold, which accounts for over 50% of total Live Well sales.